• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 144-158 of 316 results

No. 22-3

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-3 (N.D.W.Va. May. 6, 2022)

cite Cite Document
Analyze

No. 22-9

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-9 (N.D.W.Va. May. 6, 2022)

cite Cite Document
Analyze

No. 22-5

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-5 (N.D.W.Va. May. 6, 2022)

cite Cite Document
Analyze

No. 22-1

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-1 (N.D.W.Va. May. 6, 2022)

cite Cite Document
Analyze

No. 22-2

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-2 (N.D.W.Va. May. 6, 2022)

cite Cite Document
Analyze

No. 22-10

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-10 (N.D.W.Va. May. 6, 2022)

cite Cite Document
Analyze

3001 Exhibit: Exhibit 3001

Document IPR2023-00723, No. 3001 Exhibit - Exhibit 3001 (P.T.A.B. Aug. 3, 2023)

cite Cite Document
Analyze

2001 Exhibit: EX2001 Excerpt of Defendants’ Initial Invalidity Contentions, In re Oz...

Document IPR2023-00723, No. 2001 Exhibit - EX2001 Excerpt of Defendants’ Initial Invalidity Contentions, In re Ozempic Semaglutide Patent Litigation, No 122 cv 01040 CFC, D Del Oct 20, 2022 (P.T.A.B...

cite Cite Document
Analyze

2002 Exhibit: EX2002 J Lau, P Bloch, et al, “Discovery of the Once Weekly Glucago...

Document IPR2023-00723, No. 2002 Exhibit - EX2002 J Lau, P Bloch, et al, “Discovery of the Once Weekly Glucagon Like Peptide 1 GLP 1 Analogue Semaglutide,” Med Chem, 587370 7380 2015 (P.T.A.B...

cite Cite Document
Analyze

2006 Exhibit: EX2006 US Patent No 6,528,486

Document IPR2023-00723, No. 2006 Exhibit - EX2006 US Patent No 6,528,486 (P.T.A.B. Jul. 6, 2023)

cite Cite Document
Analyze

2004 Exhibit: EX2004 B Furman, N Pyne, P Flatt F O’Harte, “Targeting B cell cyclic ...

Document IPR2023-00723, No. 2004 Exhibit - EX2004 B Furman, N Pyne, P Flatt F O’Harte, “Targeting B cell cyclic adenosine monophosphate for the development of novel drugs for treating type 2 diabe...

cite Cite Document
Analyze

2003 Exhibit: EX2003 US Patent No 10,335,462

Document IPR2023-00723, No. 2003 Exhibit - EX2003 US Patent No 10,335,462 (P.T.A.B. Jul. 6, 2023)

cite Cite Document
Analyze

2007 Exhibit: EX2007 WO0069911

Document IPR2023-00723, No. 2007 Exhibit - EX2007 WO0069911 (P.T.A.B. Jul. 6, 2023)

cite Cite Document
Analyze

2008 Exhibit: EX2008 Excerpt of Plaintiffs’ Initial Responses to Defendants’ Initial I...

Document IPR2023-00723, No. 2008 Exhibit - EX2008 Excerpt of Plaintiffs’ Initial Responses to Defendants’ Initial Invalidity Contentions, In re Ozempic Semaglutide Patent Litigation, No 122 cv 01040 CF...

cite Cite Document
Analyze

2005 Exhibit: EX2005 WO9832466

Document IPR2023-00723, No. 2005 Exhibit - EX2005 WO9832466 (P.T.A.B. Jul. 6, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 10 11 12 13 14 ... >>